Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

CHANDRA BHAGAT PHARMA LTD.

NSE : NABSE : 542934ISIN CODE : INE07QQ01016Industry : Pharmaceuticals & DrugsHouse : Private

BSE102.020 (0 %)

PREV CLOSE ( ) 102.02

OPEN PRICE ( ) 114.99

BID PRICE (QTY) 92.30 (1000)

OFFER PRICE (QTY) 104.90 (1000)

VOLUME 40000

TODAY'S LOW / HIGH ( )102.00 114.99

52 WK LOW / HIGH ( ) 80160

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-03 2003

Management Info

Hemant Chandravadan Bhagat - Chairman Hemant Chandravadan Bhagat - Managing Director

Registered Office

Address Flat No. 1 & 2, Gr. Floor, 323,F, Bhagat Bhuvan Dr. Ambedkar Road,Matunga (East),
Mumbai,
Maharashtra-400019

Phone 022-24146154 / 24157205 / 24129162

Email info@cbcpharma.net, export@cbcpharma.net

Website www.cbcpharma.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE

NEWS

18Nov Chandra Bhagat Pharma informs about pr
Chandra Bhagat Pharma has informed that the 18th Annual General Meeting..

21Oct Chandra Bhagat Pharma informs about ou
Chandra Bhagat Pharma has informed that the Board of Directors of the Co..

01Oct Chandra Bhagat Pharma informs about cl
In Accordance with code of Internal Procedure and Conduct of Regulating,..

22Jun Chandra Bhagat Pharma informs about bo
Chandra Bhagat Pharma has informed that meeting of the Board of Director..

30Jan Chandra Bhagat Pharma coming with an I
Chandra Bhagat Pharma Chandra Bhagat Pharma is coming out with is coming..

Financials

Rs. in Millions

	QTR	ANNUAL 23
Net Profit		9.0400000000001
Gross Profit		11.6100000000001
Operating Profit		36.1400000000001
Net Sales		1196.72

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE) 2542.60 (12.29%)	M.Cap ( in Cr)1570.82
Neuland Laboratories (BSE) 7654.80 (1.79%)	M.Cap ( in Cr)9821.02
Mankind Pharma (BSE) 2397.40 (5.05%)	M.Cap ( in Cr)96037.07
Sanofi India (BSE) 8470.70 (0.89%)	M.Cap ( in Cr)19508.55
Solara Active Pharma (BSE) 474.10 (12.15%)	M.Cap ( in Cr)1706.58

Shareholding Pattern

	PROMOTERS	68.69%
	NON-INSTITUTION	29.09%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

CHANDRA BHAGAT PHARMA LTD.